Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,174.2
14.4 (0.46%)

 

  • STI Straits Times Index
    3,174.2
    14.4 (0.46%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,563.6
    2.6 (0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,217.0
    154.5 (0.59%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,899.5
    21.4 (0.74%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,300.1
    164.9 (0.71%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,152.1
    39.2 (0.64%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -8.2 (-0.39%)
    Index delayed 20 minutes
  • XAO XAO
    6,791.1
    76.7 (1.14%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 835.5M
  • Value: 956.9M
  • Rise: 173
  • Fall: 112
  • Unch: 542

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.230+0.015
Rex Intl0.174+0.002
Tritech0.026-0.002
YZJ Shipbldg SGD1.100+0.030
Mapletree NAC Tr1.150-0.010
MDR0.001-
AusGroup^0.030+0.002
UMS0.990+0.040
ComfortDelGro2.400+0.060
Keppel Reit1.250+0.010

World Indices

World Indices
Name Last Change
Nasdaq 8,566.7 +46.0
HSI 26,217.0 +154.5
HSCEI 10,321.8 +67.7
Jakarta 6,152.1 +39.2
Nikkei 225 23,300.1 +164.9
SSE Comp 2,899.5 +21.4
Shanghai A 3,038.2 +22.3
Shanghai B 241.6 +4.0
PSE Comp 0.0
KOSPI 2,060.7 -8.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

QT Vascular QT VASCULAR LTD.
Quotes 10 Minutes Delayed. Updated at 05 Dec 2019 14:04
Last (SGD): 0.003 Change: - High: 0.003 Remarks: -
Change (%): - Low: 0.003
Open 0.003 Yesterday's Close 0.003
Buy Price 0.002 Sell Price 0.003
Buy Volume ('000) 54,649.0 Sell Volume ('000) 68.1
Cumulative Volume ('000) 100.0 Cumulative Value 300
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.01801 Trailing EPS (SGD) e -0.00571 NAV (SGD) b 0.0067
PE a 0.167 Trailing PE f - Price / NAV b 0.4478
Dividend (SGD) d - Cash In Hand (SGD) g 0.0017 Issued & Paid-up Shares c 2,235,272,000
Dividend Yield (%) d - Price / Cash In Hand g 1.765 Treasury Shares h -
Beta - 75 Daysi 0.710 R-Squared - 75 Days(%)i 0.05 Market Cap (M) 6.706
Beta - 500 Daysi 0.642 R-Squared - 500 Days (%)i 0.22 Enterprise Value (M) 5.395
Piotroski F Score 4 Exchange Code 5I0 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 156.7521 6-Month VWAP 0.004 Free Float (%) 86.6
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Biotechnology
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 21 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference QT Vascular SGX 6.706 0.167 - 0.4478 -
Industry Biotechnology SGX 1,987.662 7.340 9.600 0.6939 4.746
Medical & Biotechnology SGX 953.082 22.335 23.184 1.3681 1.897
Index FTSE ST Catalist Index SGX 75.182 30.063 88.683 0.8961 2.277
Local Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Local Peer Suntar Eco-City^ SGX 18.828 - - 1.1312 -
Global Peer AMGEN INC NASDAQ 138,967.754 16.556 17.227 12.7179 2.392
Global Peer CSL ASX 126,043.682 46.980 46.980 16.8437 0.955
Global Peer GILEAD SCIENCES INC NASDAQ 84,448.762 15.481 31.359 4.0987 3.461
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 57,578.457 27.465 26.859 10.9602 -
Global Peer BIOGEN INC NASDAQ 52,241.568 11.791 9.682 3.7326 -
Global Peer ILLUMINA INC NASDAQ 46,992.960 56.892 48.297 10.5864 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 40,621.215 16.618 18.945 3.8671 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,548.046 329.227 17.376 2.4643 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 25,045.245 79.257 23.385 5.2749 0.757
Other Global Peers INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), WUXI BIO (HKEx), ALNYLAM PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), MODERNA INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), CRISPR THERAPEUTICS AG (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), 3SBIO (HKEx), ALLOGENE THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), AMICUS THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), NATERA INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), REGENXBIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ARVINAS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EPIZYME INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), NEXTCURE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), VIELA BIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), FRONTAGE (HKEx), FATE THERAPEUTICS (NASDAQ), RADIUS HEALTH INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CKLIFE SCIENCES (HKEx), LUMINEX CORP(DEL) (NASDAQ), VANDA PHARMACE INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), INTREXON CORP (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), VIVA BIOTECH (HKEx), AVITA MEDICAL LTD (ASX), PRECISION BIOSCIENCES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), CARA THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), POLYNOVO LIMITED (ASX), ATARA BIOTHERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), SYNTHORX INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), KADMON HLDGS INC (NYSE), CLOVIS ONCOLOGY INC (NASDAQ), MESOBLAST LTD (ASX), UROGEN PHARMA LTD (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), RETROPHIN INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), AVROBIO INC (NASDAQ), AGENUS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SINOMAB BIO-B (HKEx), VIKING THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ASCLETIS-B (HKEx), PROTHENA CORP PLC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MACROGENICS INC (NASDAQ), XBIOTECH INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), DERMIRA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ESSEX BIO-TECH (HKEx), ARDELYX INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), BELLUS HEALTH INC (NASDAQ), RECRO PHARMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), RIGEL PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MEDICINOVA INC (NASDAQ), COMPUGEN (NASDAQ), PDL BIOPHARMA INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AVID BIOSERVICES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), CUE BIOPHARMA INC (NASDAQ), LEE'S PHARM (HKEx), PERSONALIS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), GLYCOMIMETICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MANNKIND CORPORATION (NASDAQ), PFENEX INC (NYSE American), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), CABALETTA BIO INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), DPHARMA (Bursa), CHIASMA INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), BBI LIFE SCI (HKEx), X4 PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NANOVIRICIDES INC (NYSE American), NANTKWEST INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), VBI VACCINES INC CDA (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), RESAPP HEALTH LIMITED (ASX), ENZO BIOCHEM INC (NYSE), NOVAVAX INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARBUTUS BIOPHARMA CORP (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), UNI-BIO GROUP (HKEx), SESEN BIO INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), AVEO PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), HARVARD BIOSCIENCE INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), CORREVIO PHARMA CORP (NASDAQ), VERASTEM INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), IMUGENE LIMITED (ASX), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), INFLARX N V (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), OTONOMY INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), SELECTA BIOSCIENCES INC (NASDAQ), VACCINEX INC (NASDAQ), VERMILLION INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), CEL-SCI CORP (NYSE American), SYNLOGIC INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), EQUILLIUM INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), IMMUTEP LTD (ASX), TREVENA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ORTHOCELL LIMITED (ASX), INMUNE BIO INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), IDERA PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SAVARA INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ORGENESIS INC (NASDAQ), CT ENTERPRISE (HKEx), VASCULAR BIOGENICS LTD (NASDAQ), RESTORBIO INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), BELLICUM PHARMACEUTICALS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), PORT (SET), OUTLOOK THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), BIONOMICS LTD (ASX), DIAMEDICA THERAPEUTICS INC (NASDAQ), ISORAY INC (NYSE American), ONCOLYTICS BIOTECH INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), BIOSINO BIO-TEC (HKEx), SIERRA ONCOLOGY INC (NASDAQ), BIOCARDIA INC (NASDAQ), ZAFGEN INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), MEMPHASYS LTD (ASX), CONTRAFECT CORP (NASDAQ), REGENT PACIFIC (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), IBIO INC (NYSE American), NOVITA HEALTHCARE LTD (ASX), BIOTRON (ASX), SEELOS THERAPEUTICS INC (NASDAQ), RHINOMED LIMITED (ASX), BIONANO GENOMICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), EXTRAWELL PHAR (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), AZURRX BIOPHARMA INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), ANTEOTECH LIMITED (ASX), CO DIAGNOSTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), REGENEUS LTD (ASX), CELLMID LIMITED (ASX), SENESTECH INC (NASDAQ), IMMURON LIMITED (ASX), DARE BIOSCIENCE INC (NASDAQ), PRECIPIO INC (NASDAQ), OCUGEN INC (NASDAQ), PATRYS LIMITED (ASX), VAXART INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HEAT BIOLOGICS INC (NASDAQ), TOCAGEN INC (NASDAQ), ADVAXIS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), BIOCEPT INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ADALTA LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), TROVAGENE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CYCLACEL PHARMA IN (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), MEGASUN (Bursa), CCP TECHNOLOGIES LTD (ASX), MGRC (Bursa), HAO WEN HLDGS (HKEx), PLUS THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), MEDIBIO LIMITED (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BIOXYNE LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), SENECA BIOPHARMA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), NANOLLOSE LTD (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months ---
6 Months ---
1 Year --0.007
-70.00 %
Long Term Return 2 Years --0.009
-75.00 %
3 Years --0.091
-96.81 %
5 Years --0.277
-98.93 %
Annualised Return Annualised --
-59.64 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.002 - 0.010 Change From 1 Year Low +0.001 % Change From 1 Year Low (%) +50.00
Change From 1 Year High -0.007 % Change From 1 Year High (%) -70.00
2 Years Range 0.002 - 0.022 Change From 2 Years Low +0.001 % Change From 2 Years Low (%) +50.00
Change From 2 Years High -0.019 % Change From 2 Years High (%) -86.36
5 Years Range 0.002 - 0.370 Change From 5 Years Low +0.001 % Change From 5 Years Low (%) +50.00
Change From 5 Years High -0.367 % Change From 5 Years High (%) -99.19
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The Group collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

IPO Performance

Listing Date 29 Apr 2014 Full Subscription Rate (x) -
No of Placement Shares (M) 196.43 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.340 First Week Close (SGD) 0.345
Current vs IPO Price (%) -98.93 First Day Gain (%) +21.43 First Week Gain (%) +23.21

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(1.05 MB)
Part 2(0.10 MB)
Annual Report 2017 Dec 2017 Part 1(0.91 MB)
Part 2(0.08 MB)
Annual Report 2016 Dec 2016 Part 1(1.60 MB)
Part 2(0.47 MB)
Annual Report 2015 Dec 2015 Part 1(0.82 MB)
Part 2(0.20 MB)
Annual Report 2014 Dec 2014 Part 1(2.05 MB)
Part 2(0.42 MB)
Annual Report 2013 Dec 2013 Part 1(1.04 MB)
IPO Prospectus
IPO Prospectus 2014 Apr 2014 Part 1(3.55 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
05 Dec 2019 0.003 0.003 0.003 0.003 100,000 0.0030
04 Dec 2019 0.003 0.003 0.003 0.003 - -
03 Dec 2019 0.003 0.003 0.003 0.003 - -
02 Dec 2019 0.003 0.003 0.003 0.003 - -
29 Nov 2019 0.003 0.003 0.003 0.003 - -
28 Nov 2019 0.003 0.003 0.003 0.003 2,800,000 0.0030
27 Nov 2019 0.003 0.003 0.003 0.003 - -
26 Nov 2019 0.003 0.003 0.003 0.003 - -
25 Nov 2019 0.003 0.003 0.003 0.003 6,000,000 0.0030
22 Nov 2019 0.003 0.003 0.003 0.003 - -
21 Nov 2019 0.003 0.003 0.003 0.003 - -
20 Nov 2019 0.003 0.003 0.003 0.003 1,100,000 0.0030
19 Nov 2019 0.003 0.003 0.003 0.003 500,000 0.0030
18 Nov 2019 0.003 0.003 0.003 0.003 3,500,000 0.0030
15 Nov 2019 0.003 0.004 0.003 0.004 2,300,000 0.0031
14 Nov 2019 0.003 0.003 0.003 0.003 2,782,200 0.0030
13 Nov 2019 0.003 0.003 0.003 0.003 5,500,000 0.0030
12 Nov 2019 0.002 0.003 0.002 0.003 420,000 0.0029
11 Nov 2019 0.003 0.004 0.003 0.004 3,020,000 0.0030
08 Nov 2019 0.003 0.004 0.003 0.004 26,464,100 0.0030
07 Nov 2019 0.003 0.003 0.003 0.003 15,500,000 0.0030
06 Nov 2019 0.003 0.003 0.003 0.003 - -
Summary
Current 2 Weeks
(22 Nov 2019 to 05 Dec 2019)
0.003 0.003 0.003 0.003 8,900,000 -
Previous 2 Weeks
(08 Nov 2019 to 21 Nov 2019)
0.003 0.004 0.003 0.003 45,586,300 -
4 Weeks from
(10 Oct 2019 to 07 Nov 2019)
0.004 0.004 0.003 0.003 55,220,200 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.